Search

everythinglearnresearchcommunity

for

Search:↓

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Thyroid-related genes are active in skin cells and may affect autoimmune conditions.

Human skin has less GDNF and its receptor with age.

Melatonin protects skin and hair from damage and stress by acting as an antioxidant and influencing cell growth.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

Capsaicin, found in chili peppers, can slow down hair growth by affecting skin cells and hair follicles.

Beta-caryophyllene helps improve wound healing in mice, especially in females.

UVB radiation harms hair growth and health, causing cell death and other changes in human hair follicles.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Genetic research has advanced our understanding of skin diseases, but complex conditions require an integrative approach for deeper insight.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Astragalus membranaceus helps regrow hair and reduce hair loss symptoms.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Cutaneous gene therapy could become a viable treatment for skin and hair disorders with improved vector development and gene expression control.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

Applying a DNA vaccine to skin with active hair growth boosts immune response and protection against anthrax in mice.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

Protein profiling of forehead skin can help distinguish between frontal fibrosing alopecia and androgenetic alopecia.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.

Myoblast transplantation shows promise for treating various muscle and heart conditions.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.